Adverse events (AEs) in orthopedics may have a negative impact on medical care, increase costs, and reduce the effectiveness of treatment. 28 Rates of AEs in ankle arthritis are not clear. 27 Millstone et al demonstrated the effectiveness of point of care reporting for AEs and the ability to link AEs to specific risk factors, anatomic regions, and procedures. 28 Other areas of orthopedics have made inroads into capturing the impact of AEs. The Knee Society created a list of 22 complications out of all potential AEs that have a negative impact on patients. 14 Similarly, factors that have a negative impact on ankle fractures have been identified. 37 A coding system specific to increasing severity of reoperation for ankle surgery has also been reported. 40 Others have concurred that there is utility in severity weighted AE reporting. 4 Although treatment-specific AEs may not be rigorously collected in routine observational studies, sponsored clinical studies require extensive AE reporting. According to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), an adverse event is "any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment." These standards are required for clinical trials, 13 adding considerable administrative and cost burden to clinical trials even when no pharmaceutical product is involved. The value added for operative trials where the AEs are more likely to be confined to the musculoskeletal system is unclear. The current study was monitored by a data safety monitoring board (DSMB) that required the collection of all AEs from all body systems whether they were related to the surgery or the study.
The focus of this study was to gain a broader understanding of the magnitude of all AEs in the perioperative and early healing period after ankle surgery and evaluate the impact of these AEs on patient functional outcomes. Our focus was on the comparative short-term safety of the 2 treatments rather than the comparative effectiveness. The latter results will be reported in future manuscripts. The objectives were to (1) summarize the total number of AEs (ankle and nonankle) in patients undergoing ankle arthroplasty and ankle arthrodesis, (2) evaluate AE risk comparing ankle arthroplasty to ankle arthrodesis, and (3) evaluate the impact of ankle and nonankle AEs on patient-reported 12-month postoperative functional outcomes.
Methods

Study Design
This was a multisite prospective cohort study to compare ankle arthroplasty to ankle arthrodesis in the treatment of ESAA. There were 6 participating sites. Recruitment began in May 2012 and was completed in May 2015, with multiyear follow-up continuing on an annual basis. The goal of this ongoing study is to follow patients for up to 10 years or longer. The study was conducted in accordance with the procedures approved by human subjects review boards at each participating institution.
Participants
All participants presenting for operative treatment for ankle arthritis meeting the following inclusion criteria were approached for participation: adult patients between 21 and 89 years of age, ambulatory but whose primary impediment to pain-free ambulation was ankle arthritis, and a telephone number and stable mailing address. Patients were excluded if they met the following criteria: recent operative, neurologic, metabolic, or lower limb musculoskeletal problem such as severe knee or hip osteoarthritis (OA), planned complicated foot and ankle procedure requiring multiple corrections, inflammatory arthritis with multifocal disease (ie, arthritis that affects multiple parts of the body), known diabetes requiring treatment, inadequate cognitive or language function to consent to participate, or unable or unwilling to participate in follow-ups. A total of 812 consecutive patients were screened for participation. Among these, 161 (20%) did not meet study criteria and 95 (12%) were unwilling to participate, leaving 556 who consented to participate. Thirty-four of these were unable to undergo surgery and therefore withdrawn from the study, leaving 522 who consented and underwent either arthrodesis or arthroplasty based on surgeon and patient preference and discussion.
Baseline Characteristics
The following baseline risk factors were collected through interview and supplemented by the medical record (including radiographs/computed tomographic scans) sometime prior to or immediately after surgery: demographic factors (ie, gender, age, body mass index [BMI] , race, marital status, education level, employment status, and income), ankle factors (ie, cause of ESAA, previous ankle surgeries, degrees of subluxation, and severity of OA using the Kellgren-Lawrence Grading Scale), 18 comorbidities using the Functional Comorbidity Index (FCI) 11 (0-18-point scale, with higher scores representing greater comorbidity), and consumption history (ie, smoking and alcohol use).
Among the 522 participants who consented and had surgery, 419 underwent arthroplasty and 103 underwent arthrodesis. Five withdrew immediately after surgery leaving 517 who completed the full baseline assessment. (These patients were consented and had surgery but decided after completing the presurgical assessment that they did not have time for a follow-up study and asked to be withdrawn. The dropout occurred before any posttreatment outcome measures were collected.) Baseline and follow-up scores were available in 493 (95%) patients, 395 (95%) in the arthroplasty group and 98 (95%) in the arthrodesis group (Figure 1) . Concerning baseline characteristics, the 2 groups were not significantly different with regard to sex, race, marital status, education, severity of OA, alignment, and alcohol use (Table 1) . Patients who received arthroplasty were older, lighter, were less likely to be employed, less likely to have had a previous ankle surgery, and had lower functional comorbidity scores. All these differences were evaluated as potential confounders and included in the regression analyses if they met the a priori criteria.
Adverse Events, Revisions, and Major Complications
Because this was an NIH funded study with a DSMB assigned, we were required to collect and classify all AEs from all body systems. The DSMB then determined the relationship to the study. The majority of reported AEs were unrelated to the surgery or the study. For this study, we defined an AE occurrence within 12 months of surgery as "none," "non-ankle-specific" (such as urinary tract infection), or "ankle-specific." Ankle-specific AEs were further classified in the following manner: (1) major revisions defined as reoperation requiring nonweight bearing, (2) minor revisions defined as reoperation not requiring nonweight bearing, and (3) minor AEs that did not require a reoperation such as cellulitis, intraoperative fracture, and tarsal tunnel syndrome.
Patient-Reported Functional Outcomes
All patient-reported functional outcomes were assessed at baseline and at 12-month follow-up. We measured anklespecific function using the Foot and Ankle Ability Measure (FAAM). The FAAM measures several functional categories, is easily scored, and has been validated against the SF-36 physical function subscale. 25 All FAAM subscale scores are standardized on a 0% to 100% scale, with the higher percentage representing greater function. The FAAM has an established MCID of 9 points 20 and provides a wide range of functional ability items, including a higher ceiling SPORTS (SPT) subscore and an activities of daily living (ADL) subscore. Pain was assessed using 2 questions from the Chronic Pain Grade (CPG), including intensity of present ankle pain and intensity of worst ankle pain in the past 6 months. The CPG has a simple and brief format, and it demonstrates good internal consistency and reliability. 17, 39 The SF-36 Physical Component Summary (PCS) and Mental Component Summary (MCS) scores were also obtained (0-100 point scale for both).
Radiographs
The subjects had weight bearing radiographs taken of their ankle throughout the course of their clinical care based on clinical need. Any radiographic concerns identified by clinicians were logged by study coordinators. Preoperative radiographs were required to determine the baseline degree and severity of ESAA. 
Operative Procedures
The arthroplasty and arthrodesis procedures, devices, and postoperative rehabilitation protocols were consistent with the standard of care. Both procedures were performed by all surgeons. All participating surgeons were trained in hip, knee, and ankle arthroplasty, had at least 5 years of experience, and had performed at least 30 arthroplasty and 30 arthrodesis procedures to avoid errors related to operative inexperience. Arthroplasty protocols were similar among participating centers. Each surgeon used the clinically appropriate operative approach, splinted the ankles for 2 to 3 weeks, and restricted weight bearing for the first 3 to 6 weeks. For arthrodesis, a well-established technique of rigid internal fixation was implemented. Patients were allowed to walk with weight-bearing aids immediately. Weight bearing was allowed on the limb in increments over the 3 to 12 weeks after surgery. Decisions for weight bearing for both techniques were guided by radiographs.
Statistical Analysis
Differences in categorical variables between treatment groups were assessed using the χ 2 test. Differences in continuous variables were assessed using a 2-sample t test. We performed a rigorous evaluation of all potential confounders. Baseline variables that were unequally distributed between operative procedure groups were identified, based on a P value <.10. We considered a priori whether these variables would have an important effect on the outcomes of interest (adverse events and patient-reported functional outcomes) based on literature support and clinical experience. The traditional confounders age, sex, and BMI were included as covariates in all analyses. For all other potential confounding variables, we included them in each regression analysis if they were associated with any of the outcomes of interest at P <.10.
For our second aim, the association between operative procedure and risk of an AE was assessed using multinomial logistic regression with AE occurrence (none, nonankle-specific, or ankle-specific) as the dependent variable and operative procedure as the main independent effect of interest. Odds ratios (OR) and 95% confidence intervals (CIs) were estimated for ankle AE versus none and nonankle AE versus none for operative procedure in bivariable models and in multivariable models with potential confounders as covariates.
For our third aim, linear mixed effects regression was used to determine if there were differences in postoperative improvement in each primary outcome by occurrence of an AE (none, non-ankle-specific, or ankle-specific). Primary outcome measures (FAAM ADL, SPT, SF-36 PCS, SF-36 MCS, present pain, and worst pain in last 6 months) were the dependent variables. Study visit (baseline or post treatment), AE occurrence, operative procedure and potential confounders, evaluated as described above, were the independent fixed main effects. All models included main effect variables by study visit interactions to estimate the difference in postoperative improvement by AE occurrence adjusting for improvement due to the potential confounders including operative procedure. Means and 95% CIs for improvement for each AE group and differences in improvement by anklespecific AE or non-ankle-specific AE versus no AE were estimated using simultaneous inference. 15 To determine if differences in improvement by AE occurrence were modified by operative procedure, visit by AE occurrence by surgery interaction were added to the above models.
Statistical significance was set at P <.05. Estimated means in the text are presented ± standard errors and/or 95% CI. Analyses were carried using Stata 9.1 and R 3.3.2 35 with additional packages lme4, 1 multcomp, 15 lsmeans, 24 nnet, 36 and ggplot2.
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Results
Total Number of Ankle and Nonankle AEs Comparing the 2 Operative Procedures
There were a total of 628 reported AEs, 477 in the arthroplasty group and 151 in the arthrodesis group (Figure 2 ). These occurred in 261 (63%) arthroplasty patients and 67 (65%) arthrodesis patients. These AEs varied across all body systems, and the majority were not serious or related to the ankle surgery but were required for reporting purposes. There were 50 ankle-specific complications: 33 (8%) arthroplasty and 17 (17%) arthrodesis. This represents only 8% of the total number of AEs collected. There were 7 and 4 major revisions, 9 and 9 minor revisions, and 17 and 4 minor AEs, in the arthroplasty and arthrodesis groups, respectively. Because of the low event rate in each of the subcategories, we combined all ankle-specific AEs into one category for the analyses of ankle-specific AEs.
Risks of AE Occurrence Comparing Arthroplasty to Arthrodesis
Based on our evaluation of potential confounders, we selected age, BMI, sex, and FCI as baseline risk factors for AE occurrence. ORs are a measure of association between an exposure in this case a surgery type or a demographic difference-and an outcome, in this case an adverse event.
The OR represents the odds that an outcome will occur given a particular exposure, compared to the odds of the outcome occurring in the absence of that exposure. From the bivariable multinomial logistic regression, the OR for the risk of an ankle-specific AE and for a nonankle AE versus no AE was 2.23 (95% CI 1.12, 4.44) and 0.96 (95% CI 0.60, 1.55), respectively, for those receiving arthrodesis compared to arthroplasty (omnibus test for the association between AE occurrence and surgery type P = .05). In other words, there was an increase in risk for an ankle-specific adverse event in the arthrodesis group relative to the ankle replacement group but no increased risk in the non-ankle-specific AE in one group versus the other. In a multiple multinomial logistic regression of AE occurrence with covariates age, sex, BMI, FCI, and operative procedure, the OR for risk of an ankle AE versus no AE for arthrodesis compared to arthroplasty was attenuated from the bivariable model to 1.84 (95% CI 0.85, 3.98), whereas the OR for a nonankle AE versus no AE remained the same (0.96, 95% CI 0.57, 1.61, omnibus test for the association between AE occurrence and surgery type, P = .23).
Independent Effects AE on Outcomes Controlling for Operative Procedure
Based on our evaluation of potential confounders, all models included main effects and interactions with study visit for age, sex, BMI, FCI, and operative procedure. There was no difference in mean improvement between patients experiencing non-ankle-specific AEs compared to those who had no AEs in all patient-reported outcomes ( Table 2 , P ≥.80). Both of these groups experienced significant mean improvement in all outcome measures except for an only minimal improvement in the SF-36 MCS scale in those with no AE. Compared to patients with no AEs, those experiencing ankle-specific AEs had significantly less improvement in FAAM ADL, SPT and worst pain in the past 6 months by 13 points (95% CI 5, 21), 17 points (95% CI 5, 28), and 1.7 points (95% CI 0.5, 2.9), respectively. Those experiencing an ankle-specific AE improved less in SF-36 PCS scores by 3.6 points, 95% CI (-0.3, 7.4), but this did not quite reach statistical significance (P = .06). Despite these differences in improvement between those with an ankle AE versus those with no AE, those experiencing an ankle AE still had significant improvements in all outcomes except the SF-36 MCS.
There was no evidence that operative procedure modified the effect of AE status on any outcome (visit by surgery by AE occurrence interaction P >.36) except for the SPORTS subscore where 12-month improvement for those receiving arthrodesis who had an ankle specific AE was flatter (ie, no improvement) than expected given the additive independent effects of surgery type and AE occurrence. However, the visit by surgery by AE occurrence interaction was not significant (P =.09). Summary panel plots for the improvement in FAAM, ADL, and SPT scores by operative procedure and AE occurrence are presented ( Figure 3A and B). Panel plots for all other outcomes are included in the Supplemental Data (Figure S1A to D).
Discussion
The study had 3 primary goals. To summarize the total number of AEs (ankle and nonankle) during the first year after surgery in patients undergoing ankle arthroplasty and ankle arthrodesis, to evaluate AE risk comparing these 2 procedures, and to evaluate the impact of ankle and nonankle AEs on patient-reported functional outcomes.
There is growing evidence that we do not have adequate data to assess the impact of AEs in orthopedics. 23, 33 The impact of AEs on outcomes is clouded by inconsistent or unclear reporting of AEs and lack of direct linking of AE to consequences. 10, 22, 27, 40 AEs are uncommon in orthopedics but increase costs and negatively impact outcomes. 7 Millstone et al identified the likelihood of underreporting AEs in orthopedic procedures when using administrative databases and instead identified AEs at the point of care. 28 They used a reporting system with common definitions and a standardized capture system to record AEs in orthopedic operative care of the hip, knee, and spine. AEs were captured if they caused patient harm or required additional monitoring or treatment. They were able to identify different event rates in different operative procedures and to identify predictors of AEs. The AE event rate for degenerative conditions of the knee was 27% and for the hip 25%. They stratified the severity of the events but did not attempt to estimate the impact of an AE on pain or other self-reported outcomes. The majority of the AEs (90%) were in the immediate postoperative period. Only 7% were intraoperative, and 3% were in both intra-and postoperative periods.
Comparing outcomes from different treatments of ankle arthritis is in part dependent on understanding the impact of adverse events. Younger et al suggested that we track not only the event rate of complications but the nature and intensity of those complications in order to determine the value of operative treatment of ankle arthritis. 40 The authors created a system with 11 codes representing causes for reoperation and types of reoperation in the years following ankle replacement or fusion. The study established good interobserver agreement of the classification system. Impact of the different codes on patient-reported functional outcomes was not addressed.
Krause et al tracked the complications in 114 ankle replacement and 43 ankle arthrodesis patients who were followed for a minimum of 2 years after surgery using the AOS. 22 Fifty-four percent of the patients who had an ankle replacement and 26% of the patients with an ankle arthrodesis experience an AE. Each group was adversely impacted by the complications, but there was no difference in outcome in the 2 groups.
The patient experience and outcome of operative treatment of any disorder is influenced by complications of treatment. When a treatment is relatively new or infrequent, or when the surgeon is relatively inexperienced, complication rates are higher. 31 A decade ago, a review of an administrative database data in California demonstrated a much higher likelihood of secondary operation in an ankle replacement cohort compared to a cohort undergoing ankle arthrodesis. 34 A more recent study by Saltzman et al demonstrated a reversal of that ratio, with experienced surgeons reporting a lower risk of AEs in ankle replacement than ankle arthrodesis. 32 However, the 2 procedures were done by 2 different groups of highly experienced surgeons at different institutions, and the procedures were not concurrent. This is similar to our observations.
The current prospective cohort study examines a large group of patients with point of care tracking of AEs by a third party data management organization and oversight by a DSMB who did not participate in the care of the patients and met standards instituted for pharmaceutical trials. There were a number of unique findings. First, the risk of any ankle specific AE was relatively low (9.6%) with 2% of patients requiring a significant reoperation. Second, arthrodesis patients were at a higher risk of an ankle AE, but this association was attenuated and no longer statistically significant after controlling for baseline confounders. This may be the result of those undergoing fusion having higher FCI scores which were associated with experiencing an ankle-specific AE. Third, despite the occurrence of an ankle AE, these patients still had significant mean improvement in all physical and pain outcomes. However, improvement in some outcomes (FAAM ADL and SPT scores and worst pain) was less than it was for patients with no AE. Further, those undergoing arthrodesis, who experienced an ankle-specific AE, were impacted the most and improved little in the FAAM Sports subscore, though this interaction did not quite achieve statistical significance. The FAAM Sports subscale represents the highest functional level. This finding may reflect the greater difficulty in achieving high level physical function after arthrodesis (vs arthroplasty), especially if an AE is experienced in the first year. Fourth, there was no significant difference in mean improvement between patients who did not experience an AE and those who experienced a non-ankle-specific AE, despite representing 92% of all AEs. This data collection effort required a significant amount of study coordinator time and resources that could not be used for other study operations with little overall benefit. Acknowledging this, and considering focusing on anklespecific AEs only, may free investigators from tracking all AEs in future trials. Finally, the mental health score of the SF-36 did not change significantly with surgery, in contrast to the improvement found in other measures.
This study has limitations. The primary aims were to evaluate the comparative safety of 2 operative procedures and to determine the effect of AEs on patient functional outcomes. Despite a very large cohort of patients, with an overall ankle specific AE rate less than 10%, it was not possible to analyze severity of AE based on our 3 categories of minor complication, minor revision and major revision. Therefore, we combined these. The 2 treatment groups were not randomized, leading to an imbalance in the study groups and some baseline characteristics. Randomization of operative treatment for ankle arthritis has yet to be done because of the strong opinions of patients and providers on the best treatment approach. Furthermore, the AEs could not be randomized as they are naturally occurring. The observational nature of this study is subject to confounding bias when making comparisons. There is strong evidence that observational studies, if conducted with similar rigor to a clinical trial, can approximate the results of a randomized trial. The Pharmacoeconomics and Outcomes Research (ISPOR) Observational Studies (OS) Task Force published a carefully crafted statement: "It is the position of this Task Force that rigorous well designed and well executed Observational Studies can provide evidence of causal relationships." 3 Several major reviews from reputable journals comparing OS to RCTs concluded that the results are similar in a large number of studies on the same topic. 2, 6, 19 The Task force went on to conclude that if an OS is well conceived and well-performed on a relatively homogenous sample of patients, the persuasiveness of the results may be very high, especially in light of problems increasingly found in RCTs: crossover, attrition, nonadherence, and varying qualities of the participating sites and investigators, all of which serve to diminish the internal validity of the RCT. 3 This study was executed with rigorous logistical and operational procedures. Each site had a designated study coordinator who tracked all patient AEs and obtained patient functional outcomes at pre-specified time points. Data was managed by a third party with routine querying and was monitored by a separate independent organization. Because of these procedures, we achieved extremely high follow-up rates exceeding 95%. To account for baseline differences between the 2 operative groups, we performed a rigorous analysis to identify all potential confounders and included them in the regression analyses. Despite this, there is still the possibility of residual confounding.
Conclusion
Ankle specific AEs were infrequent and only weakly associated with operative procedure. Although patients improved in all functional outcomes except mental health, regardless of AE occurrence, ankle-specific AEs negatively impacted patient improvement compared to those with no AEs or a nonankle AE. The benefit of tracking nonankle AEs does not outweigh the logistical effort and cost.
